Dr. Pierone is actively involved in clinical research efforts, though he holds a special interest in body shape changes and cardiovascular complications of HIV treatment. He is a principal investigator in the FACES trial of Sculptra (poly-L-lactic acid) for HIV-related facial lipoatrophy. He is also involved in trials of streamlined antiretroviral treatment, such as FOTO (five days on, two days off), and has published a pilot study on the use of Kaletra (lopinavir/ritonavir) monotherapy in AIDS Clinical Trials.
Dr. Pierone is actively involved in the management of facial lipoatrophy and has performed over 1,000 facial filler treatments. Patients interested in Dr. Pierone's lipoatrophy treatments can find out more at his Web site, www.lipoatrophyhiv.com.
Dr. Pierone received his medical degree from the University of Florida in 1983, completed his internal medicine residency training at the University of Medicine and Dentistry in New Jersey, and trained in infectious diseases at the Mount Sinai School of Medicine in New York. He is board certified in Internal Medicine and Infectious Diseases and is a member of the International AIDS Society, the Infectious Diseases Society of America, and the American Academy of HIV Medicine.
Dr. Pierone has received research support from Abbott Virology, Avexa, Boehringer Ingelheim, Bristol-Myers Squibb, Dermik, Gilead Sciences, GlaxoSmithKline, Incyte, Koronis, Merck & Co., National Institutes of Health, Neurogesx, Pfizer, Roche Laboratories, Schering-Plough, Theratechnologies and Tibotec Therapeutics. He is a consultant and speaker for Gilead, Merck and Tibotec.
Dr. Pierone donates all compensation from his work on TheBody.com to the AIDS Research & Treatment Center of the Treasure Coast where he also serves without compensation.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.